Cargando…

Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases

Fibroblast growth factor 21 (FGF21), a stress-induced hormone in the liver, has been shown the protective functions in pathological conditions. The study investigated the association of circulating FGF21 with hepatitis B virus (HBV) infection and its related diseases. Serum FGF21 levels were measure...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Liang, Pan, Qingchun, Wu, Guangyu, Qian, Lingling, Zhang, Jing, Zhang, Lei, Fang, Qichen, Zang, Guoqing, Wang, Yudong, Lau, George, Li, Huating, Jia, Weiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705770/ https://www.ncbi.nlm.nih.gov/pubmed/29184085 http://dx.doi.org/10.1038/s41598-017-16312-6

Ejemplares similares

Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events
por: Wu, Liang, et al.
Publicado: (2020)

Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat
por: Li, Huating, et al.
Publicado: (2018)

Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease
por: Wu, Guangyu, et al.
Publicado: (2017)

Bifidobacterium adolescentis Alleviates Liver Steatosis and Steatohepatitis by Increasing Fibroblast Growth Factor 21 Sensitivity
por: Long, Xiaoxue, et al.
Publicado: (2021)

Identification of Sp1 as a Transcription Activator to Regulate Fibroblast Growth Factor 21 Gene Expression
por: Chen, Shuqin, et al.
Publicado: (2017)

Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation
por: Ye, Dewei, et al.
Publicado: (2016)

FGF21/adiponectin ratio predicts deterioration in glycemia: a 4.6-year prospective study in China
por: Liu, Dan, et al.
Publicado: (2021)

Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes
por: Lu, Jingyi, et al.
Publicado: (2015)

Elevated Serum Level of Cytokeratin 18 M65ED Is an Independent Indicator of Cardiometabolic Disorders
por: Qian, Lingling, et al.
Publicado: (2020)

Sodium Butyrate Stimulates Expression of Fibroblast Growth Factor 21 in Liver by Inhibition of Histone Deacetylase 3
por: Li, Huating, et al.
Publicado: (2012)

Metabolic phenotypes and the gut microbiota in response to dietary resistant starch type 2 in normal-weight subjects: a randomized crossover trial
por: Zhang, Lei, et al.
Publicado: (2019)

Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study
por: Yan, Hongmei, et al.
Publicado: (2011)

Serum Fibroblast Growth Factor 19 Levels Are Decreased in Chinese Subjects With Impaired Fasting Glucose and Inversely Associated With Fasting Plasma Glucose Levels
por: Fang, Qichen, et al.
Publicado: (2013)

Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose
por: Zhang, Jing, et al.
Publicado: (2017)

Fibroblast growth factor 21 as a circulating biomarker at various stages of colorectal carcinogenesis
por: Qian, Jing, et al.
Publicado: (2018)

Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer
por: Knott, ME, et al.
Publicado: (2016)

Osteocalcin attenuates high fat diet-induced impairment of endothelium-dependent relaxation through Akt/eNOS-dependent pathway
por: Dou, Jianxin, et al.
Publicado: (2014)

Circulating FGF21 proteolytic processing mediated by fibroblast activation protein
por: Zhen, Eugene Y., et al.
Publicado: (2016)

Comparison of Circulating, Hepatocyte Specific Messenger RNA and microRNA as Biomarkers for Chronic Hepatitis B and C
por: Zhang, Xiaonan, et al.
Publicado: (2014)

Acute exercise increases fibroblast growth factor 21 in metabolic organs and circulation
por: Tanimura, Yuko, et al.
Publicado: (2016)

Association between Circulating Fibroblast Growth Factor 21 and Aggressiveness in Thyroid Cancer
por: Kang, Yea Eun, et al.
Publicado: (2019)

Genome-wide association study for circulating fibroblast growth factor 21 and 23
por: Chuang, Gwo-Tsann, et al.
Publicado: (2020)

Haze, a hotbed of respiratory-associated infectious diseases, and a new challenge for disease control and prevention in China
por: Pan, Qingchun, et al.
Publicado: (2014)

Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes
por: Zhang, Jing, et al.
Publicado: (2021)

Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
por: Chavez, Alberto O., et al.
Publicado: (2009)

Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury
por: Liu, Yanlong, et al.
Publicado: (2016)

Hepatic nitric oxide synthase 1 adaptor protein regulates glucose homeostasis and hepatic insulin sensitivity in obese mice depending on its PDZ binding domain
por: Mu, Kaida, et al.
Publicado: (2019)

Circulating Fibroblast Growth Factor 21 is Associated with Subsequent Renal Injury Events in Patients Undergoing Coronary Angiography
por: Wu, Cheng-Hsueh, et al.
Publicado: (2018)

Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice
por: Lin, Zhuofeng, et al.
Publicado: (2015)

Circulating level of fibroblast growth factor 21 is independently associated with the risks of unstable angina pectoris
por: Cheng, Jing, et al.
Publicado: (2018)

Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease
por: Kohara, Marina, et al.
Publicado: (2017)

Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
por: Shen, Yun, et al.
Publicado: (2013)

Fibroblast growth factor 21 and bone homeostasis
por: Tang, Yan, et al.
Publicado: (2023)

The relationship of circulating fibroblast growth factor 21 levels with pericardial fat: The Multi-Ethnic Study of Atherosclerosis
por: Magdas, Arsenios, et al.
Publicado: (2019)

High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients
por: Han, Fei, et al.
Publicado: (2023)

Author Correction: Circulating Fibroblast Growth Factor 21 is Associated with Subsequent Renal Injury Events in Patients Undergoing Coronary Angiography
por: Wu, Cheng-Hsueh, et al.
Publicado: (2018)

Erythropoietin suppresses hepatic steatosis and obesity by inhibiting endoplasmic reticulum stress and upregulating fibroblast growth factor 21
por: Hong, Ting, et al.
Publicado: (2019)

Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells
por: Opoku, Yeboah Kwaku, et al.
Publicado: (2020)

Hepatic c-Jun regulates glucose metabolism via FGF21 and modulates body temperature through the neural signals
por: Xiao, Fei, et al.
Publicado: (2018)

A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents
por: El Sagheer, Ghada M, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ulo4jm2iu509qqosl7qilt7gqb